ACQUISITION OF SANGAMO THERAPEUTICS FRANCE S.A.S. - (Tables)

6 Months Ended

Jun. 30, 2020

Business Combinations [Abstract]

Summary of Non-controlling Interest

Non-controlling interest as of June 30, 2020 was as follows (in thousands):

	Total
Balance at December 31, 2019	$	185
Fair value of additional shares acquired	(339)
Loss attributable to non-controlling interest	(97)
Balance at June 30, 2020	$	(251)